Filtered By:
Specialty: Endocrinology
Drug: Metformin
This page shows you your search results in order of date.
Order by Relevance | Date
Total 397 results found since Jan 2013.
Research Progress of Metformin in the Treatment of Oral Squamous Cell Carcinoma
Endocrinology. 2023 Sep 20:bqad139. doi: 10.1210/endocr/bqad139. Online ahead of print.ABSTRACTOral squamous cell carcinoma (OSCC) is one of the most common malignancies with high mortality, posing a great threat to both human physical and mental health. With the advancement of scientific research, a variety of cancer therapies have been used for OSCC treatment. However, the prognosis of OSCC shows no significant improvement. Metformin has been recognized as the first-line drug for the treatment of diabetes, and recent studies have shown that metformin has a remarkable suppressive effect on tumor progression. Metformin can...
Source: Endocrinology - September 22, 2023 Category: Endocrinology Authors: Jiayi Liu Jing Zhao Xue Qiao Source Type: research
Reevaluating First-Line Therapies in Youth-onset Type 2 Diabetes
J Clin Endocrinol Metab. 2023 Aug 25:dgad508. doi: 10.1210/clinem/dgad508. Online ahead of print.ABSTRACTThe prevalence of youth-onset type 2 diabetes is growing worldwide and current first-line treatment with metformin and intensive behavior and lifestyle changes are suboptimal in over 50% of youth within two years of diagnosis. This perspective article is a call-to-action for reevaluation of existing strategies and critical appraisal of metformin as first-line therapy in youth-onset type 2 diabetes. Increased attention should be given to novel therapeutics approved in youth, including glucagon-like 1 receptor agonists, s...
Source: The Journal of Clinical Endocrinology and Metabolism - August 25, 2023 Category: Endocrinology Authors: Stephanie T Chung Faith Davis Tejal Patel Lilian Mabundo Doris E Estrada Source Type: research
Metformin, cognitive function, and changes in the gut microbiome
Endocr Rev. 2023 Aug 21:bnad029. doi: 10.1210/endrev/bnad029. Online ahead of print.ABSTRACTThe decline in cognitive function and the prevalence of neurodegenerative disorders are among the most serious threats to health in old age. The prevalence of dementia has reached 50 million people worldwide and has become one of the major public health problems. The causes of age-related cognitive impairment are multiple, complex, and difficult to determine. However, type 2 diabetes (T2D) is linked to an enhanced risk of cognitive impairment and dementia. Human studies have shown that patients with T2D exhibit dysbiosis of the gut ...
Source: ENDOCR REV - August 21, 2023 Category: Endocrinology Authors: Marisel Rosell-D íaz Jos é Manuel Fernández-Real Source Type: research
Metformin and exercise effects on postprandial insulin sensitivity and glucose kinetics in pre-and-diabetic adults
Am J Physiol Endocrinol Metab. 2023 Aug 16. doi: 10.1152/ajpendo.00118.2023. Online ahead of print.ABSTRACTThe potential interaction between metformin and exercise on glucose-lowering effects remains controversial. We studied the separated and combined effects of metformin and/or exercise on fasting and postprandial insulin sensitivity in individuals with pre- and - type 2 diabetes (T2D). Eight T2D adults (60±4 years) with overweight/obesity (32±4 kg·m-2) under chronic metformin treatment (9±6 years; 1281±524 mg·day-1) underwent four trials; a) taking their habitual metformin treatment (MET), b) substituting during 9...
Source: Am J Physiol Endocri... - August 16, 2023 Category: Endocrinology Authors: Alfonso Moreno-Caba ñas Felix Morales-Palomo Laura Álvarez-Jimenez Diego Mora-Gonzalez Juan Fernando Ortega Ricardo Mora-Rodriguez Source Type: research
Approach to the Patient with Youth-Onset Type 2 Diabetes
J Clin Endocrinol Metab. 2023 Aug 16:dgad482. doi: 10.1210/clinem/dgad482. Online ahead of print.ABSTRACTYouth-onset type 2 diabetes is a growing epidemic with a rising incidence worldwide. Although the pathogenesis and diagnosis of youth-onset type 2 diabetes are similar to adult-onset type 2 diabetes, youth-onset type 2 diabetes is unique, with greater insulin resistance, insulin hypersecretion, and faster progression of pancreatic beta cell function decline. Individuals with youth-onset type 2 diabetes also develop complications at higher rates within short periods of time compared to adults with type 2 diabetes or yout...
Source: The Journal of Clinical Endocrinology and Metabolism - August 16, 2023 Category: Endocrinology Authors: Talia A Hitt Tamara S Hannon Sheela N Magge Source Type: research
Metformin and exercise effects on postprandial insulin sensitivity and glucose kinetics in pre-and-diabetic adults
Am J Physiol Endocrinol Metab. 2023 Aug 16. doi: 10.1152/ajpendo.00118.2023. Online ahead of print.ABSTRACTThe potential interaction between metformin and exercise on glucose-lowering effects remains controversial. We studied the separated and combined effects of metformin and/or exercise on fasting and postprandial insulin sensitivity in individuals with pre- and - type 2 diabetes (T2D). Eight T2D adults (60±4 years) with overweight/obesity (32±4 kg·m-2) under chronic metformin treatment (9±6 years; 1281±524 mg·day-1) underwent four trials; a) taking their habitual metformin treatment (MET), b) substituting during 9...
Source: Am J Physiol Endocri... - August 16, 2023 Category: Endocrinology Authors: Alfonso Moreno-Caba ñas Felix Morales-Palomo Laura Álvarez-Jimenez Diego Mora-Gonzalez Juan Fernando Ortega Ricardo Mora-Rodriguez Source Type: research
Approach to the Patient with Youth-Onset Type 2 Diabetes
J Clin Endocrinol Metab. 2023 Aug 16:dgad482. doi: 10.1210/clinem/dgad482. Online ahead of print.ABSTRACTYouth-onset type 2 diabetes is a growing epidemic with a rising incidence worldwide. Although the pathogenesis and diagnosis of youth-onset type 2 diabetes are similar to adult-onset type 2 diabetes, youth-onset type 2 diabetes is unique, with greater insulin resistance, insulin hypersecretion, and faster progression of pancreatic beta cell function decline. Individuals with youth-onset type 2 diabetes also develop complications at higher rates within short periods of time compared to adults with type 2 diabetes or yout...
Source: The Journal of Clinical Endocrinology and Metabolism - August 16, 2023 Category: Endocrinology Authors: Talia A Hitt Tamara S Hannon Sheela N Magge Source Type: research
Metformin and exercise effects on postprandial insulin sensitivity and glucose kinetics in pre-and-diabetic adults
Am J Physiol Endocrinol Metab. 2023 Aug 16. doi: 10.1152/ajpendo.00118.2023. Online ahead of print.ABSTRACTThe potential interaction between metformin and exercise on glucose-lowering effects remains controversial. We studied the separated and combined effects of metformin and/or exercise on fasting and postprandial insulin sensitivity in individuals with pre- and - type 2 diabetes (T2D). Eight T2D adults (60±4 years) with overweight/obesity (32±4 kg·m-2) under chronic metformin treatment (9±6 years; 1281±524 mg·day-1) underwent four trials; a) taking their habitual metformin treatment (MET), b) substituting during 9...
Source: Am J Physiol Endocri... - August 16, 2023 Category: Endocrinology Authors: Alfonso Moreno-Caba ñas Felix Morales-Palomo Laura Álvarez-Jimenez Diego Mora-Gonzalez Juan Fernando Ortega Ricardo Mora-Rodriguez Source Type: research
